Metabolic Associated Fatty Liver Disease (MAFLD) Associated with Diabetes Mellitus, Overweight, and Metabolic Dysregulation as an Inflammatory Cascade

Document Type : Abstracts

Abstract

Metabolic Associated Faty Liver Disease, MAFLD, is a new nomenclature proposed to replace the old term NAFLD. MAFLD is a new challenge in modern medicine, due to its progressively increasing global prevalence and its associated multiple sequels. The diagnosis of MAFLD relied upon on presence of both hepatic steatosis and any of the following three metabolic conditions: overweight/obesity, type 2 diabetes mellitus, or evidence of metabolic dysregulation (MD) in lean 
individuals.
Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2
October 2023

Files

Share

How to cite

Statistics